Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naval Daver

Showing results (421-430 of 436) with videos related to

Pageof 44
Sort By:
Nature Communications|February 28, 2024
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategiesBofei Wang, Patrick K Reville, Mhd Yousuf Yassouf, et al.
Nature Communications|October 19, 2021
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapyHussein A Abbas, Dapeng Hao, Katarzyna Tomczak, et al.
Blood Cancer Journal|March 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromesAlexandre Bazinet, Alex Bataller, Kelly Chien, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Research Square|March 3, 2023
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analysesMarina Konopleva, Courtney DiNardo, Tushar Bhagat, et al.
Blood|February 1, 2023
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromesAmer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, et al.
Nature Genetics|August 11, 2025
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Nature Genetics|July 2, 2025
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk ModelCurtis A Lachowiez, Joshua F Zeidner, Jad Othman, et al.
Pageof 44

Showing results (421-430 of 436) with videos related to

Sort By:
Pageof 44
Nature Communications|February 28, 2024
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategiesBofei Wang, Patrick K Reville, Mhd Yousuf Yassouf, et al.
Nature Communications|October 19, 2021
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapyHussein A Abbas, Dapeng Hao, Katarzyna Tomczak, et al.
Blood Cancer Journal|March 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromesAlexandre Bazinet, Alex Bataller, Kelly Chien, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Research Square|March 3, 2023
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analysesMarina Konopleva, Courtney DiNardo, Tushar Bhagat, et al.
Blood|February 1, 2023
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromesAmer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, et al.
Nature Genetics|August 11, 2025
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Blood Cancer Discovery|January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Nature Genetics|July 2, 2025
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk ModelCurtis A Lachowiez, Joshua F Zeidner, Jad Othman, et al.
Pageof 44